Study at a glance
Can one blood-level cut-off define vitamin D deficiency for everyone?
This article reviews why one blood-level cut-off cannot define vitamin D deficiency perfectly for everyone. It considers studies of bone health, calcium absorption, hormone responses and laboratory measurements. The blood substance being measured is 25-hydroxyvitamin D, which is used to assess vitamin D status.
Why is there no single clear boundary for vitamin D deficiency?
Different health measurements do not all change at the same vitamin D level. Studies of parathyroid hormone, which helps control calcium, have produced widely different proposed cut-offs. Some studies did not find one clear point where the hormone stopped falling as vitamin D levels increased. These findings do not establish a deficiency boundary that applies to everyone.
What else can change the meaning of a low vitamin D result?
Calcium intake and how long vitamin D has been low affect the risk of bone disease. Season and ordinary changes within a person can also affect a blood result. Different laboratory methods may place similar samples on opposite sides of a cut-off. A small difference around that boundary does not necessarily mean a meaningful change in the body.
Are vitamin D cut-offs still useful?
Yes. They help identify increased risk and support medical and public health decisions. Very low levels that persist remain linked to bone disease risk. However, a level chosen to cover nearly everyone’s needs does not mean every person below it is deficient. Each cut-off needs to be understood in relation to its purpose and the person being assessed.
Read the full article below ↓A vitamin D deficiency cut-off is clinically useful because it converts a continuous laboratory measurement into an actionable category. The difficulty is that human physiology rarely changes at the same precise 25-hydroxyvitamin D concentration in every person. Skeletal mineralisation, parathyroid hormone, calcium absorption, dietary calcium, assay uncertainty and individual biological variation all weaken the idea that one numerical boundary can function as a universal diagnostic switch. For a shorter version of this evidence, see Physiological Limitations of Vitamin D Deficiency Cut-Offs and Diagnostic Thresholds: Study Summary.
A cut-off simplifies a continuous biological relationship
Serum 25(OH)D is measured on a continuous scale. A diagnostic rule then places a line somewhere on that scale and labels concentrations on one side differently from those on the other. The usefulness of that process is obvious: clinicians, laboratories and public-health systems need categories. But the existence of a category does not demonstrate that physiology itself contains an abrupt boundary at precisely the same concentration.
This distinction is central to Vitamin D Thresholds vs Targets. A threshold is a decision tool. Whether it corresponds to an actual biological threshold depends on the outcome being measured and the evidence establishing the relationship.
Different physiological outcomes do not produce the same threshold
Vitamin D affects calcium and phosphate physiology, bone mineralisation and parathyroid regulation, but these processes do not necessarily deteriorate at one identical concentration. Studies have therefore tried to derive vitamin D thresholds from different endpoints, including parathyroid hormone suppression, calcium absorption, bone turnover, bone mineral density, rickets and osteomalacia.
The resulting cut-offs differ because the endpoints differ. A concentration that appears adequate for maximal calcium absorption does not automatically establish the concentration required to minimise parathyroid hormone, prevent every fracture, optimise every bone marker or influence a nonskeletal outcome. Moving from one endpoint to another changes the biological question.
This is why the meaning of a laboratory concentration should be separated from the broader interpretation described in Vitamin D Status vs Vitamin D Effect.
Parathyroid hormone does not reveal one stable universal cut-off
One influential strategy has been to identify the 25(OH)D concentration above which parathyroid hormone, or PTH, stops declining. Vitamin D contributes to calcium absorption, and low vitamin D status can increase PTH as the body attempts to maintain extracellular calcium. It therefore seems plausible that the point where PTH reaches a plateau might identify vitamin D sufficiency.
In practice, studies have produced widely different results. Reviews have reported proposed PTH-related thresholds spanning roughly 25 to 125 nmol/L, or 10 to 50 ng/mL. Some datasets show a plateau, others show a gradual relationship, and others show no convincing single inflection point.
A large analysis combining observational data with vitamin D intervention studies found that PTH continued to vary across 25(OH)D categories and that supplementation could reduce PTH across a broad range of baseline concentrations. The investigators concluded that the PTH-25(OH)D relationship is not a reliable way to establish a universal vitamin D deficiency threshold.
Calcium intake changes the physiological consequences of low vitamin D
Vitamin D and calcium physiology are tightly linked. Vitamin D facilitates intestinal calcium handling, but the consequences of a low 25(OH)D concentration depend partly on how much calcium is available from the diet. This interaction makes it difficult to assign all mineralisation risk to vitamin D concentration alone.
The Global Consensus on Nutritional Rickets explicitly recognises this interaction. Rickets can result from vitamin D deficiency, low calcium intake or both. Children can develop rickets at 25(OH)D concentrations above the guideline’s deficiency boundary, while some children with low concentrations do not develop rickets. The risk becomes greater when low vitamin D status is sustained and calcium intake is inadequate.
This means that a cut-off gives information about risk but does not perfectly classify the presence or absence of disease. The broader physiology behind a measured number is considered in What Vitamin D Levels Represent.
Duration matters as well as concentration
A single 25(OH)D measurement contains limited information about duration. A person who has recently crossed below a threshold is biologically different from someone who has remained profoundly low for months. Chronic low availability gives mineral metabolism more time to become disrupted and is therefore more relevant to the development of osteomalacia or rickets than an isolated transient measurement at the same concentration.
Seasonal cycling adds another complication. A concentration measured near a winter trough can differ substantially from the same person’s summer value. This does not make seasonal low status unimportant, but it demonstrates why one value cannot automatically describe long-term exposure. Biological Noise in Vitamin D Testing explores these time-dependent influences on interpretation.
Assay variability can move a result across the diagnostic boundary
A physiological threshold is useful only if the measurement used to apply it is sufficiently accurate and comparable. Historically, 25(OH)D assays have shown meaningful between-method and between-laboratory variation. Immunoassays, chromatographic methods and LC-MS/MS systems can differ because of calibration, extraction, metabolite recognition, vitamin D-binding protein effects and other analytical factors.
Studies comparing laboratories have shown that specimens near a clinical decision level can be classified on different sides of the boundary depending on the laboratory or method. This problem becomes particularly important when a tiny numerical difference changes the label from deficient to sufficient.
Standardisation programmes involving the NIH, CDC, NIST and international reference laboratories have improved the situation, but the underlying lesson remains important: the precision implied by a hard diagnostic cut-off can exceed the precision of the measurement. The analytical background is developed in Variability in Vitamin D Measurements and Limitations of Vitamin D Blood Tests.
Small differences around a cut-off are not necessarily biological differences
Suppose one test reports 49 nmol/L and another reports 51 nmol/L. A framework using 50 nmol/L as its classification boundary can give those values different labels. That does not establish that physiology changed discontinuously between the two samples.
Measurement uncertainty, within-person biological variation and ordinary laboratory imprecision mean that values immediately around a boundary should not be interpreted as categorically different biological states without supporting context. The farther a result lies from the decision threshold, the less this particular classification problem matters.
Population requirements are not individual diagnostic requirements
The National Academies’ vitamin D framework illustrates another common source of confusion. A concentration of approximately 50 nmol/L was selected as a level expected to meet the needs of about 97.5% of the population. That is analogous to an RDA-style population coverage concept. It does not mean that every individual below 50 nmol/L is biologically deficient.
The same analysis estimated that about 40 nmol/L corresponded to the median requirement, meaning that many individuals would have requirements below the concentration selected to cover nearly everyone. Treating the higher population-protective concentration as a personal disease threshold therefore changes the meaning of the original evidence.
The statistical and biological distinction is explored in Population Reference Ranges Explained.
The definition of “sufficient” changes what is called “deficient”
Deficiency, insufficiency and sufficiency are relational categories. If sufficiency is defined as at least 50 nmol/L, the people immediately below that line may be called inadequate. If sufficiency is instead defined as at least 75 nmol/L, the same people can be reclassified as insufficient despite no change in physiology.
This is one reason prevalence estimates can change dramatically between guidelines. Vitamin D Insufficiency Explained and Vitamin D Sufficiency Explained examine how those neighbouring categories inherit the assumptions of the threshold framework used to create them.
Outcome-specific thresholds remain difficult to prove
The 2024 Endocrine Society guideline provides a modern example of the evidential problem. The panel reviewed clinical trials asking whether supplementation or screening should depend on baseline 25(OH)D. For generally healthy populations, it found that outcome-specific concentrations conferring benefit had not been established reliably enough to support routine threshold-based testing and treatment.
The panel therefore stopped endorsing the older universal 30 ng/mL target and declined to maintain specific sufficiency, insufficiency and deficiency concentrations for the healthy populations addressed by the guideline. This does not erase the established association between severe deficiency and skeletal disease. It narrows what can responsibly be inferred from higher threshold values when the desired endpoint is broader disease prevention.
A deficiency threshold is most defensible when tied to a defined purpose
The evidence becomes clearer when the question is made specific. A threshold can be used to identify increased risk of severe skeletal deficiency, to set a public-health intake policy, to classify participants in research, to define eligibility for treatment in a particular clinical setting or to describe the proportion of a population below a chosen reference concentration.
Those are legitimate uses, but they are not identical. Problems arise when a number developed for one function is presented as if it were a universal physiological law.
What cut-offs can still do well
The limitations of thresholds do not mean that all vitamin D concentrations are equally safe or that severe deficiency is merely semantic. Very low and sustained 25(OH)D concentrations are associated with impaired calcium-phosphate physiology and increased risk of rickets or osteomalacia, particularly when other nutritional vulnerabilities are present.
Cut-offs are valuable for identifying increasing risk, standardising clinical communication and guiding population policy. Their limitation is not that they are useless, but that they compress probability and biological variation into a binary label.
Interpreting a result near a deficiency boundary
A result close to a cut-off should therefore be interpreted according to the relevant clinical framework, the assay used, the person’s physiological context, the reason testing was performed and whether the result represents a persistent pattern. Small numerical differences around the line should not be granted more biological precision than the measurement and evidence can support.
This approach does not weaken deficiency diagnosis. It improves it by distinguishing a practical decision boundary from a universal biological switch. That distinction allows very low concentrations to retain their genuine clinical significance without pretending that every neighbouring number carries a sharply different physiological meaning.
Primary evidence and guidance
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. PMID: 21796828. DOI: 10.17226/13050.
Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health. J Clin Endocrinol Metab. 2011;96(3):E436-E446. PMID: 21159838. PMCID: PMC3047227. DOI: 10.1210/jc.2010-1886.
Jorde R, Grimnes G. Serum PTH is not a good marker for defining a threshold for vitamin D deficiency. Endocr Connect. 2020;9(5):396-404. PMID: 32412426. PMCID: PMC7274551. DOI: 10.1530/EC-20-0067.
Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016;101(2):394-415. PMID: 26745253. PMCID: PMC4880117. DOI: 10.1210/jc.2015-2175.
Sempos CT, Wise SA, Phinney KW, et al. Baseline Assessment of 25-Hydroxyvitamin D Assay Performance: A Vitamin D Standardization Program (VDSP) Interlaboratory Comparison Study. J AOAC Int. 2017;100(5). PMID: 28822355. DOI: 10.5740/jaoacint.17-0258.
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. PMID: 38828931. DOI: 10.1210/clinem/dgae290.
Related reading
Diagnostic Accuracy of Point-of-Care Tests to Diagnose Vitamin D Deficiency in Adults and Children: Systematic Review
The clinic questionnaires to determine implant eligibility were not described, but the stated study objectives related to evaluating outcomes in routine patients at the study clinic.
Original paper ↗Read more →Association between 25-Hydroxyvitamin D, Parathyroid Hormone, Vitamin D and Calcium Intake, and Bone Density in Healthy Adult Women: A Cross-Sectional Analysis from the D-SOL Study
This cross-sectional analysis aimed to investigate the associations of 25(OH)D and plasma PTH concentrations with bone parameters, and potential confounders, in women living in a high (England) or low (Brazil) latitude country.
Original paper ↗Read more →Interactions between Vitamin D Status, Calcium Intake and Parathyroid Hormone Concentrations in Healthy White-Skinned Pregnant Women at Northern Latitude
Little explored in pregnancy, we aimed to examine the relative importance of serum 25-hydroxyvitamin D (25(OH)D) and calcium intake on parathyroid hormone (PTH) concentrations in healthy white-skinned pregnant women.
Original paper ↗Read more →Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging
Bone health of the elderly is a major global health concern, since about 1 in 3 women and 1 in 5 men suffer from bone loss and fractures, often called osteoporosis, in old age.
Original paper ↗Read more →Arterial Structure and Function in Mild Primary Hyperparathyroidism Is Not Directly Related to Parathyroid Hormone, Calcium, or Vitamin D
We evaluated the possible vascular effects of these risk factors in patients with mild PHPT by using standard methods and new imaging techniques.
Original paper ↗Read more →Associations of Vitamin D Deficiency, Parathyroid hormone, Calcium, and Phosphorus with Perinatal Adverse Outcomes. A Prospective Cohort Study
We aimed to evaluate the association of vitamin D deficiency during early pregnancy with preterm birth.
Original paper ↗Read more →Effects of Different Dietary Interventions on Calcitriol, Parathyroid Hormone, Calcium, and Phosphorus: Results from the DASH Trial
This secondary analysis of the DASH trial aimed to determine the effect of dietary patterns on blood concentrations of calcitriol, parathyroid hormone (PTH), ionized calcium, and urinary excretion of calcium and phosphorus.
Original paper ↗Read more →Physiological Limitations of Vitamin D Deficiency Cut-Offs and Diagnostic Thresholds: Study Summary
A concise evidence summary explaining why vitamin D diagnostic thresholds cannot function as identical biological boundaries for every individual.
Read more →Aqueous Extract of Mori Folium Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats
The present study is aimed to explore whether the aqueous extract of Mori Folium (MF) exhibits bone protective effect by regulating calcium and redox homeostasis in diabetic rats, and to identify the signaling pathways involved in this process.
Original paper ↗Read more →Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium
The prevalence of low: turnover bone disease (LTBD) in peritoneal dialysis (PD) patients is higher than in hemodialysis (HD) patients.
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study
Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals.
Original paper ↗Read more →Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
However, evidence of the causal role of mineral metabolism in CAVS is still lacking.
Original paper ↗Read more →Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk
The present study investigated Ca absorption patterns with increasing levels of fortification in milk, and the response to one dose of a Ca salt.
Original paper ↗Read more →R990G Polymorphism of Calcium Sensing Receptor Gene Is Associated with High Parathyroid Hormone Levels in Subjects with Vitamin D Deficiency: A Cross-Sectional Study
Single nucleotide polymorphisms (SNPs), R990G and A986S of the calcium sensing receptor (CaSR) gene, are shown to influence response of parathyroid hormone (PTH) in subjects with optimal vitamin D levels.
Original paper ↗Read more →Seasonal variation and correlation analysis of vitamin D and parathyroid hormone in Hangzhou, Southeast China
This study aimed to describe the 25‐hydroxyvitamin D (25(OH)D) and parathyroid hormone (PTH) status of Southeast Chinese individuals influenced by season.
Original paper ↗Read more →The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
Background and objectives: Vitamin D is an essential vitamin that plays a key role in maintaining physiological calcium balance, and is also a pivotal element in the formation of bone structure.
Original paper ↗Read more →The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study
Therefore, we aimed to explore the bidirectional causal effects among serum calcium, Vit-D, PTH, and IBS at the genetic level by a two-sample Mendelian randomization (MR) analysis of the datasets from IEU OpenGWAS database.
Original paper ↗Read more →Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone
By recruiting reference population, we aimed to (1): estimate the 25(OH)D threshold that maximally inhibits the PTH, which can be defined as the cutoff value for vitamin D sufficiency; (2) establish the PTH reference interval (RI) in population with sufficient vitamin D.
Original paper ↗Read more →Vitamin D Binding Protein Genotype Is Associated with Serum 25-Hydroxyvitamin D and PTH Concentrations, as Well as Bone Health in Children and Adolescents in Finland
We examined the role of GC genotypes in S-25(OH)D status and BMD in 231 Finnish children and adolescents aged 7−19 yr.
Original paper ↗Read more →Relationship Between Total 25-Hydroxyvitamin D and Parathyroid Hormone Concentrations During Early Gestation in Indian Women
The inverse relationship between 25(OH)D and parathyroid hormone (PTH) concentrations was examined to define the breakpoint at which PTH was maximally suppressed using a segmented regression analysis.
Original paper ↗Read more →Original sources
Dietary Reference Intakes for Calcium and Vitamin D
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium.
Publication details
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. PMID: 21796828. DOI: 10.17226/13050.
Relationship between Vitamin D, Parathyroid Hormone, and Bone Health
Published in J Clin Endocrinol Metab (2011).
Publication details
Sai AJ, Walters RW, Fang X, Gallagher JC. Relationship between Vitamin D, Parathyroid Hormone, and Bone Health. J Clin Endocrinol Metab. 2011;96(3):E436-E446. PMID: 21159838. PMCID: PMC3047227. DOI: 10.1210/jc.2010-1886.
Serum PTH is not a good marker for defining a threshold for vitamin D deficiency
Published in Endocr Connect (2020).
Publication details
Jorde R, Grimnes G. Serum PTH is not a good marker for defining a threshold for vitamin D deficiency. Endocr Connect. 2020;9(5):396-404. PMID: 32412426. PMCID: PMC7274551. DOI: 10.1530/EC-20-0067.
Global Consensus Recommendations on Prevention and Management of Nutritional Rickets
Published in J Clin Endocrinol Metab (2016).
Publication details
Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016;101(2):394-415. PMID: 26745253. PMCID: PMC4880117. DOI: 10.1210/jc.2015-2175.
Baseline Assessment of 25-Hydroxyvitamin D Assay Performance: A Vitamin D Standardization Program (VDSP) Interlaboratory Comparison Study
Published in J AOAC Int (2017).
Publication details
Sempos CT, Wise SA, Phinney KW, et al. Baseline Assessment of 25-Hydroxyvitamin D Assay Performance: A Vitamin D Standardization Program (VDSP) Interlaboratory Comparison Study. J AOAC Int. 2017;100(5). PMID: 28822355. DOI: 10.5740/jaoacint.17-0258.
Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
Published in J Clin Endocrinol Metab (2024).
Publication details
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. PMID: 38828931. DOI: 10.1210/clinem/dgae290.